Table 2.
Basic information
| Prednisolone acetate group (n = 35) | Loteprednol group (n = 27) | P value | |
|---|---|---|---|
| Age (years) | 53.21 ± 11.44 | 53.75 ± 15.37 | 0.874 |
| Male, n (%) | 17 (48.57) | 22 (81.48) | 0.973 |
| Surgical method, n (%) | 0.746 | ||
| PKP | 22 (62.86) | 16 (59.26) | |
| LKP | 13 (34.14) | 11 (40.74) | |
| High risk keratoplasty | 5 (14.29) | 4 (14.81) | 0.953 |
| Graft bed size > 8.5mm | 3 (8.57) | 2 (7.41) | |
| Eccentric graft bed | 2 (5.71) | 2 (7.41) | |
| Preoperative diagnosis, n (%) | 0.225 | ||
| Leukoma | 12 (34.29) | 6 (22.22) | |
| Cornea dystrophy | 4 (11.43) | 2 (7.41) | |
| Corneal degeneration | 1 (2.85) | 2 (7.41) | |
| Keratoconus | 3 (8.57) | 1 (3.70) | |
| Infectious corneal ulcer | 12 (34.29) | 13 (48.15) | |
| Infective corneal perforation | 3 (8.57) | 3 (11.11) |
Age were tested using a student’s t-test. The gender, surgical method, high risk keratoplasty and preoperative diagnosis were analyzed using χ2 test